| Genetic testing in pheochromocytoma or functional paraganglioma L Amar, J Bertherat, E Baudin, C Ajzenberg, B Bressac-de Paillerets, ... Journal of Clinical Oncology 23 (34), 8812-8818, 2005 | 818 | 2005 |
| The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics E Valassi, A Santos, M Yaneva, M Tóth, CJ Strasburger, P Chanson, ... European journal of endocrinology 165 (3), 383-392, 2011 | 449 | 2011 |
| Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas LJ Castro-Vega, A Buffet, AA De Cubas, A Cascón, M Menara, E Khalifa, ... Human molecular genetics 23 (9), 2440-2446, 2014 | 425 | 2014 |
| Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families AF Daly, JF Vanbellinghen, SK Khoo, ML Jaffrain-Rea, LA Naves, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1891-1896, 2007 | 376 | 2007 |
| KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron H Louis-Dit-Picard, J Barc, D Trujillano, S Miserey-Lenkei, N Bouatia-Naji, ... Nature genetics 44 (4), 456-460, 2012 | 349 | 2012 |
| Ketoconazole in Cushing's disease: is it worth a try? F Castinetti, L Guignat, P Giraud, M Muller, P Kamenicky, D Drui, P Caron, ... The Journal of Clinical Endocrinology & Metabolism 99 (5), 1623-1630, 2014 | 313 | 2014 |
| Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy F De Fraipont, M El Atifi, N Cherradi, G Le Moigne, G Defaye, R Houlgatte, ... The Journal of Clinical Endocrinology & Metabolism 90 (3), 1819-1829, 2005 | 299 | 2005 |
| Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients JP Baguet, L Hammer, TL Mazzuco, O Chabre, JM Mallion, N Sturm, ... European journal of endocrinology 150 (5), 681-686, 2004 | 270 | 2004 |
| Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study R Libe, I Borget, CL Ronchi, B Zaggia, M Kroiss, T Kerkhofs, J Bertherat, ... Annals of Oncology 26 (10), 2119-2125, 2015 | 261 | 2015 |
| Duration of adrenal inhibition following a single dose of etomidate in critically ill patients M Vinclair, C Broux, P Faure, J Brun, C Genty, C Jacquot, O Chabre, ... Intensive care medicine 34, 714-719, 2008 | 260 | 2008 |
| Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience G Raverot, N Sturm, F de Fraipont, M Muller, S Salenave, P Caron, ... The Journal of Clinical Endocrinology & Metabolism 95 (10), 4592-4599, 2010 | 251 | 2010 |
| Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders S Giraud, CX Zhang, O Serova-Sinilnikova, V Wautot, J Salandre, ... The American Journal of Human Genetics 63 (2), 455-467, 1998 | 248 | 1998 |
| Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene I Schuffenecker, M Virally-Monod, R Brohet, D Goldgar, B Conte-Devolx, ... The Journal of Clinical Endocrinology & Metabolism 83 (2), 487-491, 1998 | 238 | 1998 |
| Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients J Trouillas, F Labat-Moleur, N Sturm, M Kujas, MF Heymann, ... The American journal of surgical pathology 32 (4), 534-543, 2008 | 235 | 2008 |
| Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database B Gatta-Cherifi, O Chabre, A Murat, P Niccoli, C Cardot-Bauters, ... European journal of endocrinology 166 (2), 269-279, 2012 | 232 | 2012 |
| MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines P Goudet, A Dalac, M Le Bras, C Cardot-Bauters, P Niccoli, ... The Journal of Clinical Endocrinology & Metabolism 100 (4), 1568-1577, 2015 | 222 | 2015 |
| Management of endocrine disease: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion J Young, M Haissaguerre, O Viera-Pinto, O Chabre, E Baudin, A Tabarin European journal of endocrinology 182 (4), R29-R58, 2020 | 205 | 2020 |
| Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry L Maione, T Brue, A Beckers, B Delemer, P Petrossians, F Borson-Chazot, ... European Journal of Endocrinology 176 (5), 645-655, 2017 | 195 | 2017 |
| Coupling of the alpha 2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system. O Chabre, BR Conklin, S Brandon, HR Bourne, LE Limbird Journal of Biological Chemistry 269 (8), 5730-5734, 1994 | 188 | 1994 |
| High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas MA Tichomirowa, A Barlier, AF Daly, ML Jaffrain-Rea, C Ronchi, ... European journal of endocrinology 165 (4), 509-515, 2011 | 186 | 2011 |
